Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cui Xiong

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Journal of Cellular and Molecular Medicine|March 20, 2024
MRPS16 promotes lung adenocarcinoma growth via the PI3K/AKT/Frataxin signalling axisZaixing Cheng, Kaming Xue, Cui Xiong, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 2, 2023
Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expressionXinwei Qiao, Zaixing Cheng, Kaming Xue, et al.
Journal of Cancer|February 19, 2024
Erratum: FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathway: ErratumYibin Zeng, Cui Xiong, Nan Tang, et al.
Texas Heart Institute Journal|May 2, 2023
Establishment and Verification of a Nomogram for Predicting the Probability of New-Onset Atrial Fibrillation After Dual-Chamber Pacemaker ImplantationYing Yang, Jiangting Lu, Cui Xiong, et al.
Journal of Cancer|May 8, 2023
FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathwayYibin Zeng, Cui Xiong, Nan Tang, et al.
Rheumatology and Therapy|January 19, 2020
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label StudyJing Zhang, Weiguo Wan, Liyan Miao, et al.
Biomaterials|October 1, 2008
A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligandsYong-Chao Yao, Xiao-Yong Zhan, Jing Zhang, et al.
ERJ Open Research|May 21, 2024
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trialRuchong Chen, Liping Wei, Yuanrong Dai, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A <i>Post-hoc</i> Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled TrialRuchong Chen, Yuanrong Dai, Danrong Yang, et al.
Modern Rheumatology|October 8, 2022
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analysesJie Zheng, Jieruo Gu, Yin Su, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Journal of Cellular and Molecular Medicine|March 20, 2024
MRPS16 promotes lung adenocarcinoma growth via the PI3K/AKT/Frataxin signalling axisZaixing Cheng, Kaming Xue, Cui Xiong, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 2, 2023
Tumor-associated macrophage-derived exosomes LINC01592 induce the immune escape of esophageal cancer by decreasing MHC-I surface expressionXinwei Qiao, Zaixing Cheng, Kaming Xue, et al.
Journal of Cancer|February 19, 2024
Erratum: FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathway: ErratumYibin Zeng, Cui Xiong, Nan Tang, et al.
Texas Heart Institute Journal|May 2, 2023
Establishment and Verification of a Nomogram for Predicting the Probability of New-Onset Atrial Fibrillation After Dual-Chamber Pacemaker ImplantationYing Yang, Jiangting Lu, Cui Xiong, et al.
Journal of Cancer|May 8, 2023
FAM72A promotes glioma progression by regulating mitophagy through the Pink1/Parkin signaling pathwayYibin Zeng, Cui Xiong, Nan Tang, et al.
Rheumatology and Therapy|January 19, 2020
Pharmacokinetics, Pharmacodynamics and Safety of Belimumab in Chinese Patients with Systemic Lupus Erythematosus: A Phase I, Open-Label StudyJing Zhang, Weiguo Wan, Liyan Miao, et al.
Biomaterials|October 1, 2008
A specific drug targeting system based on polyhydroxyalkanoate granule binding protein PhaP fused with targeted cell ligandsYong-Chao Yao, Xiao-Yong Zhan, Jing Zhang, et al.
ERJ Open Research|May 21, 2024
Efficacy and safety of mepolizumab in a Chinese population with severe asthma: a phase III, randomised, double-blind, placebo-controlled trialRuchong Chen, Liping Wei, Yuanrong Dai, et al.
Allergy, Asthma & Immunology Research|July 30, 2025
Clinical Remission Outcome in Chinese Patients With Severe Asthma With an Eosinophilic Phenotype Receiving Mepolizumab: A <i>Post-hoc</i> Analysis of a Phase 3, Randomized, Double-Blind, Placebo-Controlled TrialRuchong Chen, Yuanrong Dai, Danrong Yang, et al.
Modern Rheumatology|October 8, 2022
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analysesJie Zheng, Jieruo Gu, Yin Su, et al.
Pageof 3